Global Next-Generation SRT Market Analysis: Pipeline Innovation, Regulatory Landscape, and Revenue Outlook (2026–2036)
The global market for next-generation Substrate Reduction Therapies (SRTs) is entering a decisive growth phase between 2026 and 2036, driven by advances in rare disease science, favorable regulatory frameworks, and rising commercial interest in precision medicines. As healthcare systems shift from symptom management toward disease-modifying interventions, SRTs are increasingly...
0 Комментарии 0 Поделились 68 Просмотры